Kurt Anker Nielsen
Founder at Partisia Blockchain Foundation
Kurt Anker Nielsen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Collstrups Mindelegat | Chairman | 2010-05-23 | - |
Partisia Blockchain Foundation
 Partisia Blockchain Foundation Packaged SoftwareTechnology Services Partisia Blockchain Foundation provides blockchain technology services. The company is based in Zug, Switzerland. The Swiss company was founded in 1987 by Peter Frands Frandsen, Kurt Anker Nielsen, Brian Gallagher. | Founder | 1986-12-31 | - |
| President | 1986-12-31 | - |
Career history of Kurt Anker Nielsen
Former positions of Kurt Anker Nielsen
| Companies | Position | Start | End |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Director/Board Member | 2009-04-27 | 2013-04-18 |
| Independent Dir/Board Member | 2006-08-31 | 2013-04-18 | |
| NOVO NORDISK A/S | Director/Board Member | 2011-05-31 | 2013-03-19 |
| Director of Finance/CFO | 1999-12-31 | 2011-05-31 | |
| VESTAS WIND SYSTEMS A/S | Director/Board Member | 2009-11-08 | - |
| Independent Dir/Board Member | 2011-04-12 | - | |
| EQUINOR ASA | Director/Board Member | 2007-09-30 | 2009-03-24 |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | President | - | 2002-12-31 |
| Novo Industri A/S | Corporate Officer/Principal | 1988-12-31 | 1988-12-31 |
| CARLSBERG A/S | Corporate Officer/Principal | 1972-12-31 | 1972-12-31 |
| ░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░ | - | - |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Kurt Anker Nielsen
| Copenhagen Business School | Graduate Degree |
Statistics
International
| Denmark | 15 |
| Norway | 3 |
| United States | 2 |
Operational
| Director/Board Member | 10 |
| Chairman | 3 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 6 |
| Finance | 3 |
| Technology Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| NORSK HYDRO ASA | Non-Energy Minerals |
| NOVO NORDISK A/S | Health Technology |
| EQUINOR ASA | Energy Minerals |
| VESTAS WIND SYSTEMS A/S | Producer Manufacturing |
| CARLSBERG A/S | Consumer Non-Durables |
| SCANDINAVIAN INVESTMENT GROUP A/S | Finance |
| Private companies | 11 |
|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Miscellaneous |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Finance |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
Reliance A/S
 Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Commercial Services |
| Novo Industri A/S | Health Technology |
| Collstrups Mindelegat | |
Sepior ApS
 Sepior ApS Packaged SoftwareTechnology Services Sepior ApS develops cloud-based solutions. It enables organizations to encrypt data going into cloud solutions. The firm offers solutions in the form of a cloud-based key-management. Its security solution builds upon cryptography approach known as multi-party computation. The company was founded by Nicolaj Hojer Nielsen, Ivan Bjerre Damg?rd, Jakob I Pagter, Kurt Nielsen, Thomas Pelle Jakobsen and Jesper Buus Nielsen in 2013 and is headquartered in Copenhagen, Denmark. | Technology Services |
Partisia Blockchain Foundation
Partisia Blockchain Foundation Packaged SoftwareTechnology Services Partisia Blockchain Foundation provides blockchain technology services. The company is based in Zug, Switzerland. The Swiss company was founded in 1987 by Peter Frands Frandsen, Kurt Anker Nielsen, Brian Gallagher. | Technology Services |
- Stock Market
- Insiders
- Kurt Anker Nielsen
- Experience
